Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
Assessment of quality of life is an important, valid, informative, and cost-effective procedure for evaluating the efficiency of treatment in patients with breast cancer metastasizing to the bone, receiving therapy with bone-modifying agents, including targeted therapy with denosumab. The administra...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/35 |
| _version_ | 1797876138249289728 |
|---|---|
| author | T. Yu. Semiglazova V. V. Semiglazov L. V. Filatova P. V. Krivorotko V. V. Kolarkova V. F. Semiglazov |
| author_facet | T. Yu. Semiglazova V. V. Semiglazov L. V. Filatova P. V. Krivorotko V. V. Kolarkova V. F. Semiglazov |
| author_sort | T. Yu. Semiglazova |
| collection | DOAJ |
| description | Assessment of quality of life is an important, valid, informative, and cost-effective procedure for evaluating the efficiency of treatment in patients with breast cancer metastasizing to the bone, receiving therapy with bone-modifying agents, including targeted therapy with denosumab. The administration of denosumab significantly improves quality of life in patients with breast cancer metastasizing to the bone, by maintaining their general status, reducing the intensity of pain syndrome, and prevents osseous complications: pathological fractures, spinal cord compression, hypercalcemia, as well as the need for radiotherapy or surgery for bone metastases. |
| first_indexed | 2024-04-10T01:57:25Z |
| format | Article |
| id | doaj.art-3fa905d680954db9ac8cc5c6424d7883 |
| institution | Directory Open Access Journal |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| last_indexed | 2024-04-10T01:57:25Z |
| publishDate | 2014-07-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj.art-3fa905d680954db9ac8cc5c6424d78832023-03-13T08:44:31ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-07-0101-2172210.17650/1994-4098-2013-0-1-2-17-2250Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancerT. Yu. Semiglazova0V. V. Semiglazov1L. V. Filatova2P. V. Krivorotko3V. V. Kolarkova4V. F. Semiglazov5ФГБУ «Научно-исследовательский институт онкологии им. Н.Н. Петрова» Минздрава России, Санкт-ПетербургГБОУ ВПО «Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава РоссииФГБУ «Научно-исследовательский институт онкологии им. Н.Н. Петрова» Минздрава России, Санкт-ПетербургФГБУ «Научно-исследовательский институт онкологии им. Н.Н. Петрова» Минздрава России, Санкт-ПетербургФГБУ «Научно-исследовательский институт онкологии им. Н.Н. Петрова» Минздрава России, Санкт-ПетербургФГБУ «Научно-исследовательский институт онкологии им. Н.Н. Петрова» Минздрава России, Санкт-ПетербургAssessment of quality of life is an important, valid, informative, and cost-effective procedure for evaluating the efficiency of treatment in patients with breast cancer metastasizing to the bone, receiving therapy with bone-modifying agents, including targeted therapy with denosumab. The administration of denosumab significantly improves quality of life in patients with breast cancer metastasizing to the bone, by maintaining their general status, reducing the intensity of pain syndrome, and prevents osseous complications: pathological fractures, spinal cord compression, hypercalcemia, as well as the need for radiotherapy or surgery for bone metastases.https://ojrs.abvpress.ru/ojrs/article/view/35качество жизнирак молочной железыметастазы в костикостные осложненияденосумабзоледроновая кислота |
| spellingShingle | T. Yu. Semiglazova V. V. Semiglazov L. V. Filatova P. V. Krivorotko V. V. Kolarkova V. F. Semiglazov Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer Опухоли женской репродуктивной системы качество жизни рак молочной железы метастазы в кости костные осложнения деносумаб золедроновая кислота |
| title | Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer |
| title_full | Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer |
| title_fullStr | Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer |
| title_full_unstemmed | Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer |
| title_short | Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer |
| title_sort | quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer |
| topic | качество жизни рак молочной железы метастазы в кости костные осложнения деносумаб золедроновая кислота |
| url | https://ojrs.abvpress.ru/ojrs/article/view/35 |
| work_keys_str_mv | AT tyusemiglazova qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer AT vvsemiglazov qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer AT lvfilatova qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer AT pvkrivorotko qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer AT vvkolarkova qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer AT vfsemiglazov qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer |